Viking Therapeutics' weight-loss tablet shows promise in small study
Go back to Viking Therapeutics' weight-loss tablet shows promise in small study| ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) | Delayed: 34.15 -0.21 (0.61%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $34.36 | 52 Week High | $5.17 | |||
| Open | $34.79 | 52 Week Low | $0.94 | |||
| Day High | $34.98 | P/E | N/A | |||
| Day Low | $34.15 | EPS | $0.00 | |||
| Volume | 594,185 | |||||
